Immunology Market: By Drug Class, Fusion Proteins, Immunosuppressants, Polyclonal Antibody, Others), By Indication, By Distribution Channel and Region Forecast 2020-2031

email us

Immunology Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Monoclonal Antibodies (mAb), Fusion Proteins , Immunosuppressants, Polyclonal Antibody (pAb), Others), By Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Lupus, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region Forecast 2020-2031

Immunology Market size was valued at US$ 109.3 billion in 2024 and is expected to reach US$ 243.1 billion by 2031, growing at a significant CAGR of 12.1% from 2025-2031. The global market provides a detailed overview of The Immunology Market and can be segmented by Drug Class, Indication, and Distribution Channel. By drug class, the Immunology market has been segmented into Monoclonal Antibodies (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibodies (pAb), and Others. The monoclonal antibodies segment is likely to be the largest and fastest-growing segment in terms of type. Based on Indication, the immunology market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Lupus, Ankylosing Spondylitis, Inflammatory Bowel Disease, and Others. Among these, the Rheumatoid Arthritis segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on Distribution Channel, the immunology market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The hospital pharmacies segment accounted for the largest share. Retail Pharmacies is the second-largest share during the forecast period, according to Precision Business Insights.

Key Developments:

In May 2020, AbbVie, Inc. announced the acquisition of Allergan Plc with an aim to expand its presence and strengthen its position in the pharmaceuticals sector across the globe.

Download Sample

Immunology Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

12.1%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America

Immunology Market Dynamics

The increase in the prevalence rate of the different types of cancer and rheumatoid arthritis, rising government initiatives, and increasing funding from the various government and non-government organizations is driving the immunology market.

Immunology Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2025-2031
Market Size in 2024	US$ 109.3 billion
Market Size in 2031	US$ 243.1 billion
Market CAGR	12.1%
By Drug Class	Monoclonal Antibodies (mAb) Fusion Proteins Immunosuppressants Polyclonal Antibody (pAb) Others
By Indication	Rheumatoid Arthritis Psoriatic Arthritis Plaque Psoriasis Lupus Ankylosing Spondylitis Inflammatory Bowel Disease Others
By Distribution Channel	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (U.S., Canada) Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific) Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America) Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

The immunology market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The immunology market size was valued at US$ 109.3 billion in 2024 and is expected to reach US$ 243.1 billion by 2031, growing at a significant CAGR of 12.1% from 2025-2031.

Amgen Inc., Novartis AG, Janssen Global Services, LLC, Astellas Pharma inc., UCB SA, Eli Lilly and Company

North America is the fastest-growing region for immunology market

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary

2. Global Immunology Market Introduction

2.1. Global Immunology Market - Taxonomy

2.2. Global Immunology Market -Definitions

2.2.1. By Drug Class

2.2.2. By Indication

2.2.3. By Distribution Channel

2.2.4. By Region

3. Global Immunology Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Immunology Market Dynamic Factors - Impact Analysis

3.6. Global Immunology Market - Competition Landscape

4. Global Immunology Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031

4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Immunology Market, By Drug Class, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

5.1. Monoclonal Antibodies (mAb)

5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Fusion Proteins

5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Immunosuppressants

5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Polyclonal Antibody (pAb)

5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Others

5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

6. Global Immunology Market, By Indication, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.1. Rheumatoid Arthritis

6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Psoriatic Arthritis

6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Plaque Psoriasis

6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Lupus

6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Ankylosing Spondylitis

6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Inflammatory Bowel Disease

6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

6.7. Others

6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.7.3. Market Opportunity Analysis

7. Global Immunology Market, By Distribution Channel, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

7.1. Hospital Pharmacies

7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Retail Pharmacies

7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Online Pharmacies

7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

8. Global Immunology Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

8.1. North America

8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia-Pacific

8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Middle East and Africa

8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Region, 2025 - 2031

9. North America Immunology Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

9.1. Drug Class Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Monoclonal Antibodies (mAb)

9.1.2. Fusion Proteins

9.1.3. Immunosuppressants

9.1.4. Polyclonal Antibody (pAb)

9.1.5. Others

9.2. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Rheumatoid Arthritis

9.2.2. Psoriatic Arthritis

9.2.3. Plaque Psoriasis

9.2.4. Lupus

9.2.5. Ankylosing Spondylitis

9.2.6. Inflammatory Bowel Disease

9.2.7. Others

9.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. USA

9.4.2. Canada

9.5. North America Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2025 - 2031

9.6. North America Immunology Market Dynamics - Trends

10. Europe Immunology Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

10.1. Drug Class Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Monoclonal Antibodies (mAb)

10.1.2. Fusion Proteins

10.1.3. Immunosuppressants

10.1.4. Polyclonal Antibody (pAb)

10.1.5. Others

10.2. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Rheumatoid Arthritis

10.2.2. Psoriatic Arthritis

10.2.3. Plaque Psoriasis

10.2.4. Lupus

10.2.5. Ankylosing Spondylitis

10.2.6. Inflammatory Bowel Disease

10.2.7. Others

10.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Germany

10.4.2. UK

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Russia

10.4.7. Rest of Europe

10.5. Europe Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2025 - 2031

10.6. Europe Immunology Market Dynamics - Trends

11. Asia-Pacific Immunology Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

11.1. Drug Class Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Monoclonal Antibodies (mAb)

11.1.2. Fusion Proteins

11.1.3. Immunosuppressants

11.1.4. Polyclonal Antibody (pAb)

11.1.5. Others

11.2. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Rheumatoid Arthritis

11.2.2. Psoriatic Arthritis

11.2.3. Plaque Psoriasis

11.2.4. Lupus

11.2.5. Ankylosing Spondylitis

11.2.6. Inflammatory Bowel Disease

11.2.7. Others

11.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. China

11.4.2. India

11.4.3. Japan

11.4.4. ASEAN

11.4.5. Australia & New Zealand

11.4.6. Rest of Asia-Pacific

11.5. Asia-Pacific Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2025 - 2031

11.6. Asia-Pacific Immunology Market Dynamics - Trends

12. Latin America Immunology Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

12.1. Drug Class Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Monoclonal Antibodies (mAb)

12.1.2. Fusion Proteins

12.1.3. Immunosuppressants

12.1.4. Polyclonal Antibody (pAb)

12.1.5. Others

12.2. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Rheumatoid Arthritis

12.2.2. Psoriatic Arthritis

12.2.3. Plaque Psoriasis

12.2.4. Lupus

12.2.5. Ankylosing Spondylitis

12.2.6. Inflammatory Bowel Disease

12.2.7. Others

12.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Argentina

12.4.4. Rest of Latin America

12.5. Latin America Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2025 - 2031

12.6. Latin America Immunology Market Dynamics - Trends

13. Middle East and Africa Immunology Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)

13.1. Drug Class Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Monoclonal Antibodies (mAb)

13.1.2. Fusion Proteins

13.1.3. Immunosuppressants

13.1.4. Polyclonal Antibody (pAb)

13.1.5. Others

13.2. Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Rheumatoid Arthritis

13.2.2. Psoriatic Arthritis

13.2.3. Plaque Psoriasis

13.2.4. Lupus

13.2.5. Ankylosing Spondylitis

13.2.6. Inflammatory Bowel Disease

13.2.7. Others

13.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. Gulf Cooperation Council (GCC) Countries

13.4.2. Israel

13.4.3. South Africa

13.4.4. Rest of MEA

13.5. MEA Immunology Market - Opportunity Analysis Index, By Drug Class, By Indication, By Distribution Channel, and Country, 2025 - 2031

13.6. MEA Immunology Market Dynamics - Trends

14. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)

14.2.1. Pfizer, Inc.

14.2.2. F. Hoffmann-La Roche Ltd.

14.2.3. AbbVie, Inc.

14.2.4. Bristol-Mayers Squibb Company

14.2.5. Merck Sharp & Dohme Corp.

14.2.6. Novartis AG

14.2.7. Janssen Global Services, LLC

14.2.8. Amgen Inc.

14.2.9. Astellas Pharma inc.

14.2.10. UCB SA

14.2.11. Eli Lilly and Company

14.2.12. Allergan plc.

15. Research Methodology

16. Key Assumptions and Acronyms

Key Market Players

AbbVie, Inc.
Bristol-Mayers Squibb Company
Pfizer, Inc.
Hoffmann-La Roche Ltd.
Allergan plc.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Global Services, LLC
Amgen Inc.
Astellas Pharma inc.
UCB SA
Eli Lilly and Company

Related Industry Reports

Perfusion Systems Market

Upadacitinib API Market

Opicapone API Market

Darolutamide API Market